Sihuan Pharmaceutical Holdings Group Ltd.

SHPHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$428-$161-$1,915$417
Dep. & Amort.$258$226$339$279
Deferred Tax$0$0$134$413
Stock-Based Comp.$418$89$90$59
Change in WC-$14$111-$224-$472
Other Non-Cash$9-$66$1,623-$30
Operating Cash Flow$244$199$46$665
Investing Activities
PP&E Inv.-$71-$125-$402-$601
Net Acquisitions$35$15$88-$153
Inv. Purchases-$9,119-$10,091-$16,163-$20,042
Inv. Sales/Matur.$9,646$10,468$15,451$20,193
Other Inv. Act.$267-$96-$635$266
Investing Cash Flow$758$170-$1,661-$338
Financing Activities
Debt Repay.-$291-$31$165$294
Stock Issued$0$0$0$3
Stock Repurch.-$20-$34$0-$206
Dividends Paid-$177-$299-$1,316-$123
Other Fin. Act.-$770-$56$912$784
Financing Cash Flow-$1,258-$420-$239$751
Forex Effect$0$0$0$0
Net Chg. in Cash-$256-$50-$1,854$1,078
Supplemental Information
Beg. Cash$3,779$3,829$5,682$4,604
End Cash$3,522$3,779$3,829$5,682
Free Cash Flow$58-$96-$356$64
Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF) Financial Statements & Key Stats | AlphaPilot